MedPath

Effect of consumption of Gonal-F and Menogan on the fertility of infertile patients with Polycystic Ovary Syndrome

Phase 2
Conditions
Polycystic ovary syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20171030037093N10
Lead Sponsor
Vice chancellor for research, Shahrekord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
100
Inclusion Criteria

Infection with polycystic ovary syndrome
Age less than 40 years
Induction of in vitro fertilization
No response to treatment with clomiphene citrate in patients

Exclusion Criteria

Blocking both tubes as the cause of infertility
Hypothalamic amenorrhea as the cause of infertility
Early ovarian failure as the cause of infertility
Infertility due to severe male or azoospermia
Diabetes
Problems with thyroid problems
Kidney Disease
Sensitization to letrozole and clomiphene

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The number of ocits earned. Timepoint: 7 and 12 days after the intervention. Method of measurement: Vaginal ultrasound.;Endometrial thickness. Timepoint: 7 and 12 days after the intervention. Method of measurement: Measurement.;Number of cases of empty follicular syndrome. Timepoint: 7 and 12 days after the intervention. Method of measurement: Vaginal ultrasound.;The number of cases of ovarian hyperstimulation syndrome. Timepoint: 7 and 12 days after the intervention. Method of measurement: Based on the amount of free fluid in the abdomen with ultrasound.;Human Chorionic Gonadotropin. Timepoint: 16 days after the transfer of embryos. Method of measurement: Experiment.;Fetal heart rate. Timepoint: 6 weeks after fertilization. Method of measurement: FHR machine.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath